Slovenia resumes use of AstraZeneca vaccine after brief suspension
Ljubljana, 18 March - Slovenia has decided to resume using the AstraZeneca vaccine after the European Medicines Agency (EMA) assessed AstraZeneca's Covid-19 vaccine "safe and effective" after a review of possible blood clot risks.
The rest of this news item is available to subscribers.
The news item consists of 758 characters (without spaces) or 139 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.